Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: A case report

The Lancet Infectious Diseases

Volumn 15, Issue 9, 2015, Pages 1034-1040

  Schibler, Manuel ^a   Vetter, Pauline ^a   Cherpillod, Pascal ^a,b   Petty, Tom J ^b,c   Cordey, Samuel ^a,b   Vieille, Gaël ^a   Yerly, Sabine ^a,b   Siegrist, Claire Anne ^b   Samii, Kaveh ^a   Dayer, Julie Anne ^a   Docquier, Mylène ^b   Zdobnov, Evgeny M ^b,c   Simpson, Andrew J H ^d   Rees, Paul S C ^e   Sarria, Felix Baez ^f   Gasche, Yvan ^a   Chappuis, François ^a   Iten, Anne ^b   Pittet, Didier ^b   Pugin, Jérôme ^a   Kaiser, Laurent ^a,b   more..

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e BARTS HEALTH NHS TRUST   (United Kingdom)

^f Hospital Universitario Dr Carlos J Finlay   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; FAVIPIRAVIR; IMIPENEM; MONOCLONAL ANTIBODY; AMIDE; ANTIVIRUS AGENT; PYRAZINE DERIVATIVE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; EBOLA HEMORRHAGIC FEVER; FOLLOW UP; HALF LIFE TIME; HIGH THROUGHPUT SEQUENCING; HUMAN; PHYSICIAN; PRIORITY JOURNAL; SIERRA LEONE; VIRAL CLEARANCE; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; EBOLAVIRUS; GENETICS; HEMORRHAGIC FEVER, EBOLA; VIROLOGY; VIRUS SHEDDING;

ADULT; AMIDES; ANTIVIRAL AGENTS; EBOLAVIRUS; GENOME, VIRAL; HALF-LIFE; HEMORRHAGIC FEVER, EBOLA; HUMANS; PYRAZINES; VIRAL LOAD; VIRUS SHEDDING;

EID: 84940467204     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00229-7     Document Type: Article

References (32)

1. Ebola situation report WHO, (accessed April 2, 2015). http://apps.who.int/ebola/current-situation/ebola-situation-report-1-april-2015-0.
2. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014, 371:2092-2100.
3. Ansumana R, Jacobsen KH, Idris M, et al. Ebola in Freetown area, Sierra Leone-a case study of 581 patients. N Engl J Med 2015, 372:587-588.
4. Dallatomasinas S, Crestani R, Squire JS, et al. Ebola outbreak in rural west Africa: epidemiology, clinical features and outcomes. Trop Med Int Health 2015, 20:448-454.
5. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015, 372:40-47.
6. Heymann DL, Barakamfitiye D, Szczeniowski M, Muyembe-Tamfum JJ, Bele O, Rodier G Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo. J Infect Dis 1999, 179(suppl 1):S283-S286.
7. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A Ebola virus disease in west Africa-clinical manifestations and management. N Engl J Med 2014, 371:2054-2057.
8. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014, 371:2402-2409.
9. Parra JM, Salmeron OJ, Velasco M The first case of Ebola virus disease acquired outside Africa. N Engl J Med 2014, 371:2439-2440.
10. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014, 371:2394-2401.
11. Wolf T, Kann G, Becker S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet 2015, 385:1428-1435.
12. Cox E, Borio L, Temple R Evaluating Ebola therapies-the case for RCTs. N Engl J Med 2014, 371:2350-2351.
13. Ebrahim S, Squires N, Diaz MB, et al. Ebola control: the Cuban approach. Lancet 2014, 384:2022.
14. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014, 514:47-53.
15. Oestereich L, Ludtke A, Wurr S, Rieger T, Munoz-Fontela C, Gunther S Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 2014, 105:17-21.
16. Petty TJ, Cordey S, Padioleau I, et al. Comprehensive human virus screening using high-throughput sequencing with a user-friendly representation of bioinformatics analysis: a pilot study. J Clin Microbiol 2014, 52:3351-3361.
17. Langmead B, Salzberg SL Fast gapped-read alignment with Bowtie 2. Nat Methods 2012, 9:357-359.
18. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014, 345:1369-1372.
19. Danecek P, Auton A, Abecasis G, et al. The variant call format and VCFtools. Bioinformatics 2011, 27:2156-2158.
20. Edgar RC MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004, 32:1792-1797.
21. Rice P, Longden I, Bleasby A EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000, 16:276-277.
22. Guindon S, Gascuel O A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52:696-704.
23. Junier T, Zdobnov EM The Newick utilities: high-throughput phylogenetic tree processing in the UNIX shell. Bioinformatics 2010, 26:1669-1670.
24. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004, 78:10370-10377.
25. Carroll SA, Towner JS, Sealy TK, et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol 2013, 87:2608-2616.
26. Hoenen T, Safronetz D, Groseth A, et al. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science 2015, 348:117-179.
27. Zhang Y, Scheuermann RH 2014 Ebola outbreak-genome sequence variation analysis (accessed Jan 13, 2015). http://www.viprbrc.org/brcDocs/documents/announcements/Ebola/ViPR_scientific_report_Ebola_genome_SNP_20141016.pdf.
28. Kugelman JR, Sanchez-Lockhart M, Andersen KG, et al. Evaluation of the potential impact of ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. MBio 2015, 6:e02227-e02314.
29. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999, 179(suppl 1):S1-S7.
30. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007, 196(suppl 2):S142-S147.
31. Nkoghe D, Leroy EM, Toung-Mve M, Gonzalez JP Cutaneous manifestations of filovirus infections. Int J Dermatol 2012, 51:1037-1043.
32. Zaki SR, Shieh WJ, Greer PW, et al. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999, 179(suppl 1):S36-S47.